INS and metabolic disease: Elevated glucocorticoid levels inhibit insulin secretion by pancreatic β cells and reduce insulin sensitivity in the liver, skeletal muscle, and adipose tissue14, thereby increasing the risk of diabetes15, 16, a metabolic disease characterised by insulin resistance and low-grade inflammation that is one of the leading causes of disability and mortality in modern societies.